Farms.com Home   News

MASC To Delay Deducting Premiums Owing On Forage Claims

Manitoba Agricultural Services Corporation (MASC) will not be deducting premiums owing from any forage claim indemnities paid to clients from now until September 30th.

Normally, premiums would be deducted prior to claim payments being made.

Other changes include:

- making advance payments on forage claims, with plans to finalize forage claims as quickly as possible, and
- allowing livestock grazing on low yield forage fields or after a first cut of forage without counting that grazed production against their forage claim.

Producers may also explore options to put their crops to alternate use.

Currently, oats, barley, triticale, fall rye, and all wheat types can be put to alternate use and used for greenfeed, silage, or grazing, however producers must contact MASC before doing so.

MASC is applying a quality adjustment factor to appraisals on crops that are being put to alternate use under the AgriInsurance program.

Adjustors will use normal appraisal procedures, however appraisals will be reduced by 40 per cent to account for the expected lower quality of grain based on a five-year average.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.